Effects of Feedback From Self-Monitoring Devices on Lifestyle Changes in Prediabetes Workers: A 3-Month Randomized Controlled Trial (Preprint)

2020 ◽  
Author(s):  
Tomohisa Nagata ◽  
Sona-Sanae Aoyagi ◽  
Minekazu Takahashi ◽  
Masako Nagata ◽  
Koji Mori
Keyword(s):  
Blood Glucose ◽  
Health Behaviors ◽  
Controlled Trial ◽  
Intervention Group ◽  
Control Group ◽  
Self Monitoring ◽  
Glucose Levels ◽  
Randomized Controlled ◽  
Blood Glucose Levels ◽  
Daily Exercise

BACKGROUND Although lifestyle interventions are useful in prevention and management of diabetes, they can be expensive and time-consuming. There is some evidence for the effectiveness of automated mobile technology for health self-monitoring, however, no studies have used such devices with prediabetes workers. OBJECTIVE We aimed to examine the effectiveness of a 3-month digital self-monitoring device on glucose levels and health behaviors of prediabetes workers in Japan. The primary outcome was blood glucose levels and the secondary outcomes were changes in health behaviors and BMI. METHODS A two-arm randomized controlled trial was conducted with workers from 23 organizations. The intervention group (n=50, data analyzed for n=46) wore an armband activity monitor, a body composition monitor, and a blood pressure monitor for 3 months and received semi-automated weekly email messages tailored to their device data. The control group (n=53, data analyzed for n=48) engaged in no self-monitoring. Messages were developed by a physician and a dietician. Post-intervention changes in blood glucose levels, BMI, and health behaviors were compared between the intervention and control groups using blood tests and device data. RESULTS At the end of 3 months, the intervention group showed significantly lower blood glucose levels (HbA1c [%]: intervention mean 6.4 vs. control mean 6.6; Cohen d=0.7; 95% CI 0.2-1.1; P=.009) and significantly greater motivation to increase their daily exercise than the control group. There were no significant between-group differences in BMI or health behaviors. CONCLUSIONS Mobile digital self-monitoring was effective in improving blood glucose levels and motivation to increase daily exercise in prediabetes workers. The use of digital health devices is a cost-effective way of implementing health self-monitoring for large numbers of individuals in the workplace. CLINICALTRIAL This study is registered with the University Hospital Medical Information Network (UMIN000023651).

scholarly journals The Potential of Noni (Moringa citrifolia) in Lowering Blood Glucose Levels in Diabetes Mellitus Patients

BIOEDUSCIENCE ◽  
2020 ◽  
Vol 4 (2) ◽  
pp. 120-123
Author(s):  
Putri Dafriani ◽  
Mutiara Karamika ◽  
Siska Sakti Anggraini ◽  
Roza Marlinda
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Intervention Group ◽  
Control Group ◽  
Diabetic Patients ◽  
Test Results ◽  
Glucose Levels ◽  
Glucose Testing ◽  
Blood Glucose Levels ◽  
Reduce Blood Glucose

Background: Diabetes Mellitus is a chronic metabolic disorder caused by insulin resistance. Noni juice has the potential as herbal medicine which believed to reduce blood glucose levels. This study aims to determine the effect of noni juice on blood sugar levels on diabetic patients. Methods: This study used 16 respondents. They divided two groups, a control group and a treatment group. Each group consists of 8 respondents. The intervention group received 150 ml of noni juice which was given once a day for ten days. Glucose testing was carried out by the glucose-check method. The blood was taken from the respondent's fingertips capillary. The blood glucose levels between the control group and the intervention group were analyzed using independent t-test. Results: The average blood glucose level in the intervention group was 199.88 mg/dl, while the control group was 326.25 mg/dl. The test results of the mean blood glucose levels between the control group and the intervention group had a significant difference with a value of p = 0.003 (p ≤ 0.05). This indicates a significant effect between blood glucose levels in the control group and the intervention group. Conclusion: Noni can reduce blood glucose levels because it contains flavonoid. It has a hypoglycemic effect. Health workers can suggest consuming noni juice to decrease blood glucose in diabetic patients.    

scholarly journals Effectiveness of a Dyadic Buddy App for Smoking Cessation: Randomized Controlled Trial

10.2196/27162 ◽  
2021 ◽  
Vol 23 (9) ◽  
pp. e27162
Author(s):  
Philipp Schwaninger ◽  
Corina Berli ◽  
Urte Scholz ◽  
Janina Lüscher
Keyword(s):  
Randomized Controlled Trial ◽  
Smoking Cessation ◽  
Controlled Trial ◽  
Intervention Group ◽  
The Self ◽  
Daily Smoking ◽  
Control Group ◽  
Smoking Abstinence ◽  
Self Monitoring ◽  
Randomized Controlled

Background Tobacco smoking is one of the biggest public health threats. Smartphone apps offer new promising opportunities for supporting smoking cessation in real time. This randomized controlled trial investigated the effectiveness of an app that encourages individuals to quit smoking with the help of a social network member (buddy) in daily life. Objective The objective of this study is to test the effectiveness of the SmokeFree buddy app compared with a control group with self-reported smoking abstinence and carbon monoxide (CO)–verified smoking abstinence as primary outcomes and self-reports of smoked cigarettes per day (CPD) as a secondary outcome. Methods A total of 162 adults who smoked participated in this single-blind, two-arm, parallel-group, intensive longitudinal randomized controlled trial. Around a self-set quit date (ie, 7 days before the self-set quit date and 20 days after) and 6 months later, participants of the intervention and control groups reported on daily smoking abstinence and CPD in end-of-day diaries. Daily smoking abstinence was verified via daily exhaled CO assessments. This assessment was administered via an app displaying results of exhaled CO, thus addressing self-monitoring in both groups. In addition, participants in the intervention group used the SmokeFree buddy app, a multicomponent app that facilitates social support from a buddy of choice. Results A significant reduction in CPD from baseline to the 6-month follow-up was observed among participants in both groups. Multilevel analyses revealed no significant intervention effect on self-reported and CO-verified daily smoking abstinence at the quit date and 3 weeks later. However, CPD was lower at the quit date and 3 weeks later in the intervention group than in the control group. No significant differences between groups were found for any outcome measures 6 months after the quit date. Overall, low app engagement and low perceived usefulness were observed. Conclusions Despite some encouraging short-term findings on the amount of smoking, the SmokeFree buddy app did not have beneficial effects on smoking abstinence over and above the self-monitoring control condition. Future studies should examine whether and what support processes can be effectively stimulated and how app use can be improved to better achieve this goal. Trial Registration ISRCTN Registry 11154315; https://www.isrctn.com/ISRCTN11154315 International Registered Report Identifier (IRRID) RR2-10.1186/s12889-019-7723-z

scholarly journals Effectiveness of a Dyadic Buddy App for Smoking Cessation: Randomized Controlled Trial (Preprint)

2021 ◽  
Author(s):  
Philipp Schwaninger ◽  
Corina Berli ◽  
Urte Scholz ◽  
Janina Lüscher
Keyword(s):  
Randomized Controlled Trial ◽  
Smoking Cessation ◽  
Controlled Trial ◽  
Intervention Group ◽  
The Self ◽  
Daily Smoking ◽  
Control Group ◽  
Smoking Abstinence ◽  
Self Monitoring ◽  
Randomized Controlled

BACKGROUND Tobacco smoking is one of the biggest public health threats. Smartphone apps offer new promising opportunities for supporting smoking cessation in real time. This randomized controlled trial investigated the effectiveness of an app that encourages individuals to quit smoking with the help of a social network member (<i>buddy</i>) in daily life. OBJECTIVE The objective of this study is to test the effectiveness of the SmokeFree buddy app compared with a control group with self-reported smoking abstinence and carbon monoxide (CO)–verified smoking abstinence as primary outcomes and self-reports of smoked cigarettes per day (CPD) as a secondary outcome. METHODS A total of 162 adults who smoked participated in this single-blind, two-arm, parallel-group, intensive longitudinal randomized controlled trial. Around a self-set quit date (ie, 7 days before the self-set quit date and 20 days after) and 6 months later, participants of the intervention and control groups reported on daily smoking abstinence and CPD in end-of-day diaries. Daily smoking abstinence was verified via daily exhaled CO assessments. This assessment was administered via an app displaying results of exhaled CO, thus addressing self-monitoring in both groups. In addition, participants in the intervention group used the SmokeFree buddy app, a multicomponent app that facilitates social support from a buddy of choice. RESULTS A significant reduction in CPD from baseline to the 6-month follow-up was observed among participants in both groups. Multilevel analyses revealed no significant intervention effect on self-reported and CO-verified daily smoking abstinence at the quit date and 3 weeks later. However, CPD was lower at the quit date and 3 weeks later in the intervention group than in the control group. No significant differences between groups were found for any outcome measures 6 months after the quit date. Overall, low app engagement and low perceived usefulness were observed. CONCLUSIONS Despite some encouraging short-term findings on the amount of smoking, the SmokeFree buddy app did not have beneficial effects on smoking abstinence over and above the self-monitoring control condition. Future studies should examine whether and what support processes can be effectively stimulated and how app use can be improved to better achieve this goal. CLINICALTRIAL ISRCTN Registry 11154315; https://www.isrctn.com/ISRCTN11154315 INTERNATIONAL REGISTERED REPORT RR2-10.1186/s12889-019-7723-z

scholarly journals A randomized, controlled trial of oral versus intravenous fluids for lowering blood glucose in emergency department patients with hyperglycemia

CJEM ◽  
2014 ◽  
Vol 16 (03) ◽  
pp. 214-219 ◽  
Author(s):  
Sanjay Arora ◽  
Marc A. Probst ◽  
Laura Andrews ◽  
Marissa Camilion ◽  
Andrew Grock ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Blood Glucose ◽  
Adverse Events ◽  
Controlled Trial ◽  
Fluid Administration ◽  
Intravenous Fluids ◽  
Glucose Levels ◽  
Randomized Controlled ◽  
Blood Glucose Levels ◽  
The Mean

ABSTRACT Objectives: Blood glucose can be lowered via insulin and/or fluid administration. Insulin, although efficacious, can cause hypoglycemia and hypokalemia. Fluids do not cause hypoglycemia or hypokalemia, but the most effective route of fluid administration has not been well described. This study compared the efficacy and safety of oral versus intravenous fluids for reducing blood glucose in patients with hyperglycemia. Methods: We conducted a prospective, nonblinded, randomized, controlled trial. Inclusion criteria were blood glucose &gt; 13.9 mmol/L, age &gt; 18 years, and ability to tolerate oral fluids. Subjects were excluded for critical illness, contraindication to fluids, and/or hyperglycemia therapy prior to enrolment. Subjects were randomized to receive oral bottled water or intravenous normal saline (maximum 2 L) over 2 hours. The primary outcome of interest was a change in blood glucose at 2 hours across treatment arms. Results: The 48 subjects were randomized. Baseline blood glucose levels and total amount of fluid received were similar between the two groups. The mean decrease in blood glucose at 2 hours was similar for both treatment arms: a mean decrease of 3.4 mmol/L (20.2 mmol/L to 16.8 mmol/L) in the oral fluid group versus a mean decrease of 4.0 mmol/L (19.7 mmol/L to 15.7 mmol/L) in the intravenous fluid group. The mean difference between groups was −0.6 mmol/L (95% confidence interval −2.3–1.2; p = 0.51). No adverse events were observed in either group. Conclusion: In this unblinded randomized trial, oral and intravenous fluids were equally efficacious in lowering blood glucose levels in stable hyperglycemic patients and no adverse events were noted. Physicians should be mindful that, although similar, the reduction in blood glucose was modest in both groups.

scholarly journals Effect of Trigona honey on Blood glucose levels Diabetes Mellitus In Balb/c Mice

2020 ◽  
Vol 9 (5) ◽  
pp. 314-317
Author(s):  
Tri Damayanty Syamsul ◽  
◽  
Rosdiana Natzir ◽  
Marhaen Hardjo ◽  
Hasyim Kasim ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Secretion ◽  
Blood Glucose ◽  
Daily Intake ◽  
Intervention Group ◽  
Total Phenolic ◽  
Control Group ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Body Tissues

Introduction Diabetes Mellitus (DM) is a multicultural metabolic disease characterized by hyperglycemia due to abnormalities in insulin secretion, insulin action, or both. Abnormalities in insulin secretion or action cause problems in the metabolism of carbohydrates, fats, and proteins. DM Type II is characterized by the occurrence of insulin resistance in body tissues. Trigona honey is rich in phenolic compounds because it is food collected by bees from plants. The total phenolic content in honey is highly correlated with antioxidant activity. In this study, we aimed to see the different effects of trigona honey (Tetragonula sp) on plasma insulin and blood glucose levels in mice with diabetes mellitus. Methods. Balb/c mice (n= 28) were randomly assigned into the control group (n=7), negative control, positive control, and intervention group which received a daily intake of trigona honey (n= 14). Results. showed that administration of trigona honey can increase administration of the metformin. This is caused because honey contains high antioxidants and contains bioactive compounds such as alkaloids, flavonoids, triterpenoids, and phenol compounds. Conclusion. Daily consumption of trigona honey has a remarkable potential to decrease the blood glucose, thus it can contribute to the prevention of the diabetes mellitus development.

scholarly journals Pengaruh Terapi Dzikir Terhadap Kadar Glukosa Darah Pasien Diabetes Melitus Tipe 2

2020 ◽  
Vol 10 (1) ◽  
pp. 41-47
Author(s):  
Sitti Fatimah M. Arsad ◽  
Erna Rochmawati ◽  
Arianti Arianti
Keyword(s):  
Blood Glucose ◽  
Metabolic Disorders ◽  
Intervention Group ◽  
Control Group ◽  
Test Design ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Post Test ◽  
Diabetes Melitus

Abstract Diabetes mellitus is a chronic disease with metabolic disorders in the form of increased blood glucose levels caused by disruption of insulin secretion or insulin efficacy. Management of diabetes can be done by pharmacology or nonphamacology therapy. One of the nonpharmacological therapies is dhikr therapy. The study design used quasy experiment with the control group pre-post test design. The collected samples are 40 diabetes patients with simple random technique. The research sample was divided into 2 groups,control and intervention group, each of which was 20 respondents. Data analysis uses independent t-test. The results showed that dzikir therapy of sentences thayibah, asmaul husna and prayers performed every day for 2 weeks could significantly reduce patients blood glucose levels (p = 0.000) or p <0.05. Key Words : Dhikr Therapy, Blood Glucose Level, Type 2 Diabetes Melitus

scholarly journals EFEKTIVITAS PENGGUNAAN BOOKLET TERHADAP TINGKAT KEPATUHAN MINUM OBAT PASIEN DM TIPE 2 DI PUSKESMAS WUA-WUA KOTA KENDARI TAHUN 2018

2020 ◽  
Vol 6 (2) ◽  
pp. 81
Author(s):  
Sabarudin Sabarudin ◽  
Henny Kasmawati ◽  
Rini Hamsidi ◽  
Waode Istiqamah Madjid ◽  
Andi Nafisah Tendri Adjeng
Keyword(s):  
Blood Glucose ◽  
Intervention Group ◽  
Control Group ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Type 2 Dm ◽  
Before And After ◽  
Adherence Scale ◽  
Scale 8

AbstrakDiabetes Melitus (DM) adalah penyakit metabolik kronik yang ditandai dengan meningkatnya kadar glukosa darah. Kepatuhan pengobatan yang rendah terhadap terapi pengobatan pada pasien DM tipe 2 dapat mengakibatkan peningkatan resiko biaya pengobatan serta peningkatan komplikasi penyakit. Salah satu cara untuk meningkatkan kepatuhan terhadap pengobatan dapat dilakukan dengan pemberian edukasi. Edukasi dapat dilakukan dengan berbagai cara salah satunya dengan pemberian booklet. Penelitian ini bertujuan untuk mengetahui tingkat kepatuhan minum obat pasien DM tipe 2 sebelum dan setelah pemberian booklet dilihat dari kadar Glukosa Darah Sewaktu (GDS) dan skor Morisky Medication Adherence Scale-8 (MMAS-8) dan mengetahui hubungan antara kadar GDS dan skor MMAS-8 terhadap tingkat kepatuhan minum obat pasien DM tipe 2 di Puskesmas Wua-Wua Kota Kendari Tahun 2018. Jenis penelitian ini adalah penelitian quasi eksperimental dengan sampel sebanyak 40 pasien DM tipe 2 yang dibagi menjadi 2 kelompok yaitu 20 pasien kelompok kontrol dan 20 pasien kelompok intervensi. Kadar glukosa darah sewaktu dan skor MMAS-8 diukur sebelum dan setelah empat minggu pemberian intervensi. Hasil penelitian menunjukkan bahwa terdapat perbedaan tingkat kepatuhan minum obat pasien DM tipe 2 di Puskesmas Wua-Wua Kota Kendari sebelum dan setelah pemberian booklet. Berdasarkan kadar GDS, kelompok kontrol sebelum dan setelah pemberian booklet yaitu 296,2 mg/dL turun menjadi 261,85 mg/dL, sedangkan kelompok intervensi yaitu 275,7 mg/dL turun menjadi 198,1 mg/dL. Berdasarkan skor MMAS-8 pada kelompok kontrol sebelum dan setelah pemberian booklet yaitu 3,4 menjadi 2,35 sedangkan kelompok intervensi yaitu 4,45 menjadi 0,8. Hasil uji korelasi Spearman menunjukkan bahwa terdapat hubungan yang kuat (r=0,783) antara kadar glukosa darah sewaktu dengan skor MMAS-8 pada pasien DM tipe 2 dalam menggambarkan tingkat kepatuhan pasien dengan taraf kepercayaan p=0,000 (p<0,05), dimana nilai p menunjukkan bahwa edukasi DM melalui pemberian booklet efektif membantu meningkatkan kepatuhan pasien yang dapat dilihat dari skor MMAS-8 rendah dan kadar GDS yang rendah.Kata kunci: DM Tipe 2,  MMAS-8, Booklet, Kepatuhan AbstractDiabetes mellitus (DM) is chronic metabolic disease characterized by increased blood glucose levels. Low medication compliance for treatment therapy in patients with type 2 diabetes can result in increased risk of treatment costs and increased disease complications. One way to improve adherence of treatment can be done by providing education. Education can be done in various ways one of them is by giving booklets. This study aims to determine the level of compliance for taking medication of patients with type 2 DM before and after the administration of the booklet seen from the level of Blood Glucose While (GDS) and Morisky Medication Adherence Scale-8 (MMAS-8) scores and determine the relationship between GDS levels and MMAS-scores 8 to the level of compliance for taking medication of patients with type 2 DM in Wua-Wua Health Center, Kendari City in 2018. This research is quasi-experimental study type with 40 patients with type 2 DM divided into 2 groups: 20 control group and 20 intervention group. Blood glucose levels and MMAS-8 scores were measured before and after four weeks of intervention. The results showed that there were differences in the level of compliance for taking medication of type 2 DM patients at Wua-Wua Health Center in Kendari City before and after the booklet was given. Based on the level of GDS, the control group before and after the administration of the booklet was 296.2 mg / dL down to 261.85 mg / dL, while the intervention group that was 275.7 mg / dL fell to 198.1 mg / dL. Based on MMAS-8 scores in the control group before and after the administration of the booklet, it was 3.4 to 2.35 while the intervention group was 4.45 to 0.8. The Spearman correlation test results showed that there was strong relationship (r = 0.783) between the blood glucose levels when with MMAS-8 scores in type 2 DM patients in describing the level of compliance of patients with level p = 0,000 (p <0.05), p-value indicates that DM education through effective booklet administration trust helps improve patient compliance which can be seen from low MMAS-8 scores and low GDS levels.Keywords: DM Type 2, MMAS-8, Booklet, Compliance

Sign in / Sign up

Export Citation Format

Share Document